RxNorm Semantic Concepts Index - 219
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "219".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 219 | Acid phosphomonoesterase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219 | Acid phosphomonoesterase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219 | Acid phosphomonoesterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 219 | Acid phosphomonoesterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2190 | Cefsulodin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2190 | Cefsulodin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190 | Cefsulodin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190 | Cefsulodin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190 | Cefsulodin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219008 | P & S | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2190090 | Carbidopa- and levodopa-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190090 | Carbidopa- and levodopa-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190091 | Carmellose- and hydroxyapatite-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190091 | Carmellose- and hydroxyapatite-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2190091 | Carmellose- and hydroxyapatite-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219010 | P-A-C Analgesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219013 | P-V-Tussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219015 | P.T.E.-5 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219016 | P1E1 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219017 | P2E1 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219018 | P3E1 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219019 | P4E1 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2190190 | Dextromethorphan-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190190 | Dextromethorphan-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219020 | P6E1 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219021 | PALS chlorophyll copper complex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219023 | PBZ | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219025 | PC Pen VK | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219026 | PC-10 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219027 | PC-CAP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2190290 | Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190290 | Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190291 | Human C1 esterase inhibitor-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190291 | Human C1 esterase inhibitor-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190292 | Human alpha1 proteinase inhibitor-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190292 | Human alpha1 proteinase inhibitor-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190293 | Human anti-D immunoglobulin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190293 | Human anti-D immunoglobulin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190294 | Human chorionic gonadotropin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190294 | Human chorionic gonadotropin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190295 | Dihydroergotamine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190295 | Dihydroergotamine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190296 | Human immunoglobulin G-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190296 | Human immunoglobulin G-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219030 | PMB | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219033 | PP-Cap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219037 | Pacaps | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219038 | Pacerone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2190390 | Human protein C-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190390 | Human protein C-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190391 | Proxymetacaine-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190391 | Proxymetacaine-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190391 | Proxymetacaine-containing product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2190490 | Donepezil-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190490 | Donepezil-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219050 | Pain-A-Lay Gargle | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219051 | Pain-Eze | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219052 | Pain-Gesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219055 | Pamine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2190590 | Doxycycline-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190590 | Doxycycline-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219061 | Panacet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219063 | Panafil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219064 | Panafil White | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219066 | Panase | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219067 | Pancof HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219068 | Pancof XP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219073 | Pancreatic EC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219074 | Pancreatic EC 4 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219075 | Pancreatin 4X | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2190790 | Hydroxyamfetamine- and tropicamide-containing product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2190790 | Hydroxyamfetamine- and tropicamide-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190790 | Hydroxyamfetamine- and tropicamide-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190791 | Lamivudine- and nevirapine- and stavudine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190791 | Lamivudine- and nevirapine- and stavudine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190792 | Lamotrigine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190792 | Lamotrigine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21908 | Cyclamate sulfamidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21908 | Cyclamate sulfamidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21908 | Cyclamate sulfamidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21908 | Cyclamate sulfamidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219083 | Pandel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219084 | Panex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219085 | Panex 500 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219088 | Panlor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2190890 | Lansoprazole-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190890 | Lansoprazole-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190891 | Product containing simvastatin in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190891 | Product containing simvastatin in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190892 | Product containing sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2190892 | Product containing sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219095 | Panokase | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219098 | Panretin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219099 | Panritis Forte | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2190991 | Hydroxyapatite-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2190991 | Hydroxyapatite-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2190991 | Hydroxyapatite-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191 | Ceftazidime | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2191 | Ceftazidime | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2191 | Ceftazidime | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2191 | Ceftazidime | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2191 | Ceftazidime | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2191 | Ceftazidime | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 219100 | Panscol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219101 | Panshape M | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219102 | Panthoderm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219104 | Papacon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219106 | Para-Time S. R. | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219107 | Paradione | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219108 | Parafon Forte DSC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219109 | Parcaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2191090 | Levonorgestrel-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191090 | Levonorgestrel-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219110 | Pardryl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219111 | Paremyd | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219113 | Paser D/R | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219114 | Patanol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219115 | Pavabid Plateau | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219116 | Pavacot | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219117 | Pavagen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219118 | Paxarel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219119 | Paxipam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2191190 | Para-aminohippuric acid-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191190 | Para-aminohippuric acid-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191191 | Phenylbutyric acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191191 | Phenylbutyric acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191192 | Product containing recombinant human antithrombin III in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191192 | Product containing recombinant human antithrombin III in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191193 | Product containing revefenacin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191193 | Product containing revefenacin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191195 | Lidocaine- and prilocaine-containing product in dental dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191195 | Lidocaine- and prilocaine-containing product in dental dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191196 | Loratadine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191196 | Loratadine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219121 | Pedi-Cort V | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219122 | Pedi-Dri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219123 | Pedi-Pro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2191290 | Paracetamol-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191290 | Paracetamol-containing product in oromucosal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2191290 | Paracetamol-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191291 | Product containing rimabotulinumtoxinB in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191291 | Product containing rimabotulinumtoxinB in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191294 | Product containing risperidone in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191294 | Product containing risperidone in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191295 | Product containing rizatriptan in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191295 | Product containing rizatriptan in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219131 | Pediacof | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219134 | Pediamist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219135 | Pediapap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219136 | Pediapred | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2191390 | Colestyramine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191390 | Colestyramine-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2191390 | Colestyramine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21914 | Cycletanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 21914 | Cycletanide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21914 | Cycletanide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21914 | Cycletanide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 219140 | Pediotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219141 | Pedituss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219146 | Pen-Vee K | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219147 | Penecort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219148 | Penederm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2191490 | Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191490 | Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2191490 | Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191491 | Dyclonine-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191491 | Dyclonine-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191492 | Loteprednol- and tobramycin-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191492 | Loteprednol- and tobramycin-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191493 | Pituitary follicle stimulating hormone- and pituitary luteinizing hormone-containing product in parenteral dose form | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2191493 | Pituitary follicle stimulating hormone- and pituitary luteinizing hormone-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191493 | Pituitary follicle stimulating hormone- and pituitary luteinizing hormone-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191494 | Pituitary follicle stimulating hormone-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191494 | Pituitary follicle stimulating hormone-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191496 | Product containing salmon calcitonin in nasal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191496 | Product containing salmon calcitonin in nasal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191497 | Product containing selegiline in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191497 | Product containing selegiline in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191498 | Chromic phosphate (32-P)-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191498 | Chromic phosphate (32-P)-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191499 | Meclozine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191499 | Meclozine-containing product in oromucosal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2191499 | Meclozine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219150 | Pentazine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2191501 | Antidiuretic hormone-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191501 | Antidiuretic hormone-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191502 | Aripiprazole-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191502 | Aripiprazole-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191503 | Asenapine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191503 | Asenapine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191504 | Citalopram-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191504 | Citalopram-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191505 | Equine antithymocyte immunoglobulin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191505 | Equine antithymocyte immunoglobulin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191506 | Prednisolone-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191506 | Prednisolone-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191507 | Alprazolam-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191507 | Alprazolam-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191508 | Aspirin- and glycine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191508 | Aspirin- and glycine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191509 | Aspirin-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191509 | Aspirin-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219151 | Pentolair | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2191510 | Baclofen-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191510 | Baclofen-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191511 | Clonazepam-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191511 | Clonazepam-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191512 | Clopenthixol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191512 | Clopenthixol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191513 | Clopenthixol-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191513 | Clopenthixol-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191514 | Clostridium histolyticum collagenase-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191514 | Clostridium histolyticum collagenase-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191515 | Esterified estrogen- and methyltestosterone-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191515 | Esterified estrogen- and methyltestosterone-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191516 | Product containing zolmitriptan in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191516 | Product containing zolmitriptan in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191517 | Product containing Varicella-zoster virus antibody in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191517 | Product containing Varicella-zoster virus antibody in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191518 | Product containing vardenafil in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191518 | Product containing vardenafil in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191519 | Product containing Vaccinia human immune globulin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191519 | Product containing Vaccinia human immune globulin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219152 | Pentrax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2191520 | Product containing tuberculin purified protein derivative in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191520 | Product containing tuberculin purified protein derivative in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191521 | Product containing tramadol in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191521 | Product containing tramadol in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191522 | Product containing testosterone in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191522 | Product containing testosterone in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191523 | Product containing zolpidem in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191523 | Product containing zolpidem in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219153 | Pentrax Gold | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219157 | Pepto Diarrhea Control | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219158 | Perchloracap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2191590 | Fluorescein stain- and oxybuprocaine-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191590 | Fluorescein stain- and oxybuprocaine-containing product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2191590 | Fluorescein stain- and oxybuprocaine-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191591 | Clotrimazole-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191591 | Clotrimazole-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191592 | Coagulation factor VIII- and von Willebrand factor-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191592 | Coagulation factor VIII- and von Willebrand factor-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2191593 | Etacrynic acid-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2191593 | Etacrynic acid-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2191593 | Etacrynic acid-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219160 | Percolone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219164 | Perfect Choice | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219167 | Perio Med | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219168 | PerioChip | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219169 | Periogard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219170 | Periostat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219171 | Perisine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219172 | Permitil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219176 | Peroxin A | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219177 | Peroxin A 10 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219178 | Peroxyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219179 | Persa-Gel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219182 | Pertussin CS Childrens | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219185 | Petrola | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219187 | Phanasin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2191891 | salicylic acid 2 % Topical Solution (148 ML) / benzoyl peroxide 5 % MG/ML Topical Lotion (47 ML) / salicylic acid 2 % Medicated Liquid Soap (118 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 2191891 | salicylic acid 2 % Topical Solution (148 ML) / benzoyl peroxide 5 % MG/ML Topical Lotion (47 ML) / salicylic acid 2 % Medicated Liquid Soap (118 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2191891 | salicylic acid 2 % Topical Solution (148 ML) / benzoyl peroxide 5 % MG/ML Topical Lotion (47 ML) / salicylic acid 2 % Medicated Liquid Soap (118 ML) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 219190 | Pharmagesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219191 | Phazyme | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219193 | Phen-Lax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219195 | Phenagesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219198 | Phenaphen with Codeine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2192 | Ceftizoxime | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2192 | Ceftizoxime | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192 | Ceftizoxime | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192 | Ceftizoxime | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192 | Ceftizoxime | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219201 | Phenazo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219203 | Phendiet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2192090 | Crisantaspase-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192090 | Crisantaspase-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192091 | Etonogestrel-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192091 | Etonogestrel-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192092 | Famotidine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192092 | Famotidine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192093 | Fenoterol- and ipratropium-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192093 | Fenoterol- and ipratropium-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192094 | Metoclopramide-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192094 | Metoclopramide-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192095 | Betamethasone- and calcipotriol-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192095 | Betamethasone- and calcipotriol-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219211 | Phenobel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219213 | Phenolax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219215 | Phentercot | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219218 | Phentride | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2192190 | Betamethasone- and neomycin-containing product in nasal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192190 | Betamethasone- and neomycin-containing product in nasal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192191 | Betamethasone- and neomycin-containing product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192191 | Betamethasone- and neomycin-containing product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192192 | Betamethasone-containing product in nasal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192192 | Betamethasone-containing product in nasal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192193 | Betamethasone-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192193 | Betamethasone-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219223 | Phenylgesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219225 | Phenylhistine DH | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219227 | Phenylhistine Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219228 | Paracetamol- and phenyltoloxamine-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 219228 | Paracetamol- and phenyltoloxamine-containing product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 219228 | Paracetamol- and phenyltoloxamine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 219228 | Paracetamol- and phenyltoloxamine-containing product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2192290 | Boric acid- and salicylic acid-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192290 | Boric acid- and salicylic acid-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192291 | Botulism immunoglobulin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192291 | Botulism immunoglobulin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219231 | Phicon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219232 | Phillips Gel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219233 | Phillips Milk of Magnesia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219235 | Phos-Flur | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219236 | Phoslo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219238 | Phrenilin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219239 | Phrenilin Forte | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2192390 | Cyanocobalamin (57-Co)-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192390 | Cyanocobalamin (57-Co)-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192391 | Cyanocobalamin (58-Co)-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192391 | Cyanocobalamin (58-Co)-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21924 | Cyclic-CMP phosphodiesterase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21924 | Cyclic-CMP phosphodiesterase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21924 | Cyclic-CMP phosphodiesterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 219240 | Phyllocontin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219241 | Physiolyte | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219242 | Physiosol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219244 | Pilocar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2192490 | Fluorescein stain- and proxymetacaine-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192490 | Fluorescein stain- and proxymetacaine-containing product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2192490 | Fluorescein stain- and proxymetacaine-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219252 | Pilostat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219253 | Pima brand of potassium iodide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219254 | Pin-X | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219257 | Pinworm brand of Pyrantel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2192590 | Miconazole-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192590 | Miconazole-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192591 | Mirtazapine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192591 | Mirtazapine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192592 | 4-hydroxybutyric acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192592 | 4-hydroxybutyric acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219261 | Plasma-Lyte 56 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219266 | Plegine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219267 | Pletal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219268 | Pneumomist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2192690 | Bovine hyaluronidase-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192690 | Bovine hyaluronidase-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192691 | Mucin- and xylitol-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192691 | Mucin- and xylitol-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192693 | AbobotulinumtoxinA-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192693 | AbobotulinumtoxinA-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192694 | Buprenorphine- and naloxone-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192694 | Buprenorphine- and naloxone-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192695 | Frangula- and Sterculia gum-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192695 | Frangula- and Sterculia gum-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192696 | Gelatin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192696 | Gelatin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192697 | Indigo carmine-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2192697 | Indigo carmine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192697 | Indigo carmine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192698 | Neomycin- and prednisolone-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192698 | Neomycin- and prednisolone-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192699 | Neomycin- and prednisolone-containing product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192699 | Neomycin- and prednisolone-containing product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219270 | Podactin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2192700 | Iodinated (125-I) human serum albumin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192700 | Iodinated (125-I) human serum albumin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192701 | Iodohippurate (123-I) sodium-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192701 | Iodohippurate (123-I) sodium-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192702 | Norcholestenol iodomethyl (131-I)-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192702 | Norcholestenol iodomethyl (131-I)-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192703 | Amlodipine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192703 | Amlodipine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219273 | Podofin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2192790 | Ammonium lactate- and salicylic acid-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192790 | Ammonium lactate- and salicylic acid-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192791 | Product containing sodium iodide (131-I) in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192791 | Product containing sodium iodide (131-I) in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192792 | Product containing sodium iodide (131-I) in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192792 | Product containing sodium iodide (131-I) in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192793 | Product containing sodium perborate in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192793 | Product containing sodium perborate in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2192794 | Product containing sodium thiosalicylate in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2192794 | Product containing sodium thiosalicylate in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219281 | Poly Iron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219282 | Poly Pred | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219289 | Poly-Dex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219290 | Poly-Histine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219291 | Poly-Histine CS | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219293 | Poly-Tussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219294 | Poly Tussin XP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219298 | Poly-Vi-Sol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2193 | Ceftriaxone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2193 | Ceftriaxone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2193 | Ceftriaxone | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2193 | Ceftriaxone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2193 | Ceftriaxone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2193 | Ceftriaxone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 219301 | Poly-Vi-Sol with Iron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219305 | Polycarb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219306 | Polycillin-PRB | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219307 | Polycin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219308 | Polycitra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219309 | Polycitra-K | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219311 | Polydine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219313 | Polygesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219314 | Product containing polymyxin B and trimethoprim (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 219314 | Product containing polymyxin B and trimethoprim (medicinal product) | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 219314 | Product containing polymyxin B and trimethoprim (medicinal product) | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 219315 | iron polysaccharide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 219317 | Polytar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219321 | Polytracin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219324 | Pontocaine Ophthalmic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219330 | Povidex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219331 | Povidex Peri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219332 | Povidine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219333 | Poxi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219334 | Pramosone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219335 | Prandin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219336 | Prax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219339 | Pred-G | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219341 | Pred-Ject-50 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219342 | Predacort 50 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219344 | Predaject-50 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219345 | Predalone 50 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219346 | Predate-50 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219347 | Predcor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219348 | Predicort RP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219349 | Predicort-50 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219350 | Prednicen-M | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219351 | Prednisol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219354 | Prefrin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219356 | Prelone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219357 | Prelu-2 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219362 | Prempro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219396 | Pretz-D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219397 | Prevalite | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219399 | Preven EC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2194 | Cefuroxime | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2194 | Cefuroxime | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2194 | Cefuroxime | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2194 | Cefuroxime | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2194 | Cefuroxime | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 219400 | Prevident | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219403 | Pri-Cortin 50 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219407 | Primatene Dual Action | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219408 | Primatene Mist Inhaler | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219411 | Principen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219412 | Prinzide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219413 | Priscoline Hydrochloride | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219418 | ProStep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219419 | Proamatine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219420 | Probax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219421 | Procanbid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219422 | Procort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219425 | Proctocream | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219426 | Proctofoam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2194290 | 3',5'-cyclic-nucleotide phosphodiesterase inhibitor-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194290 | 3',5'-cyclic-nucleotide phosphodiesterase inhibitor-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194291 | Amfetamine and/or amfetamine derivative-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2194291 | Amfetamine and/or amfetamine derivative-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194291 | Amfetamine and/or amfetamine derivative-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219431 | Profenal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219437 | Prolex DH | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219438 | Prolex DM | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2194390 | Calcium electrolyte- and colecalciferol-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194390 | Calcium electrolyte- and colecalciferol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2194390 | Calcium electrolyte- and colecalciferol-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219440 | Promacot | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219442 | Promethegan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219443 | Prominol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219448 | Pronto Shampoo & Cream Rinse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2194490 | Calcium phosphate- and carmellose-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194490 | Calcium phosphate- and carmellose-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2194490 | Calcium phosphate- and carmellose-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194492 | Isophane insulin- and recombinant human soluble insulin-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194492 | Isophane insulin- and recombinant human soluble insulin-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2194492 | Isophane insulin- and recombinant human soluble insulin-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21945 | cycloadiphenine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 21945 | cycloadiphenine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21945 | cycloadiphenine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219454 | Propa P.H. | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219455 | Propa P.H. Acne Mask | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219458 | Propa P.H. Skin Cleanser Normal/Sensitive | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2194590 | Amylase- and endopeptidase- and triacylglycerol lipase-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194590 | Amylase- and endopeptidase- and triacylglycerol lipase-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194591 | Carmellose- and hydroxyapatite-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194591 | Carmellose- and hydroxyapatite-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2194591 | Carmellose- and hydroxyapatite-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194592 | Human anti-D immunoglobulin-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194592 | Human anti-D immunoglobulin-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219460 | Propan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219461 | Propatuss Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219462 | Propecia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219464 | Propoxyphene Compound 65 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219465 | Propulsid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219469 | ProSom | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2194691 | Product containing programmed cell death protein 1 inhibitor (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194691 | Product containing programmed cell death protein 1 inhibitor (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194692 | Product containing radioactive isotope (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194692 | Product containing radioactive isotope (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219470 | Prostigmin Bromide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219472 | Protectol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219475 | Protilase | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219478 | Protostat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219479 | Protuss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2194790 | Oxygen and/or oxygen compound-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194790 | Oxygen and/or oxygen compound-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194791 | Oxygen radioisotope-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194791 | Oxygen radioisotope-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194792 | Product containing silicon and/or silicon compound (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194792 | Product containing silicon and/or silicon compound (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194793 | Product containing sodium channel blocker (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194793 | Product containing sodium channel blocker (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219482 | Protuss D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219484 | Provigil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219485 | Provisc | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219487 | Proxacol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219488 | Prulet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2194890 | Cetyl alcohol- and colfosceril- and tyloxapol-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194890 | Cetyl alcohol- and colfosceril- and tyloxapol-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2194892 | Phenylalanine ammonia-lyase-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2194892 | Phenylalanine ammonia-lyase-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21949 | cyclobenzaprine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 21949 | cyclobenzaprine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 21949 | cyclobenzaprine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 21949 | cyclobenzaprine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 21949 | cyclobenzaprine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 219496 | Pseudo-gest | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219501 | Pseudofed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219506 | Pseudoval | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219507 | Psorcon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219509 | Psorigel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219512 | Purge | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219513 | Purinethol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219519 | Pyrinyl II | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2195190 | Product containing rhenium and/or rhenium compound (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195190 | Product containing rhenium and/or rhenium compound (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219521 | Pyrinyl Liquid Shampoo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219523 | Q-Acin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219524 | Q-B | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219529 | Q-Fed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2195290 | Piperazine and/or piperazine derivative-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195290 | Piperazine and/or piperazine derivative-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195291 | Pituitary follicle stimulating hormone- and pituitary luteinizing hormone-containing product | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2195291 | Pituitary follicle stimulating hormone- and pituitary luteinizing hormone-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195291 | Pituitary follicle stimulating hormone- and pituitary luteinizing hormone-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219531 | Q-Gesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219533 | Q-Lax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219534 | Q-Naftate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219535 | Q-Nol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219536 | Q-Nol Extra Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219538 | Q-Profen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2195390 | Aclidinium- and formoterol-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195390 | Aclidinium- and formoterol-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195391 | Product containing samarium and/or samarium compound (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195391 | Product containing samarium and/or samarium compound (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21954 | cyclobutyrol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 219542 | Q-Tuss with Hydrocodone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219542 | Q-Tuss with Hydrocodone | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 219546 | Q-V Tussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219547 | QM-260 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219549 | Quarzan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219555 | Quibron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219557 | Caffedrine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219558 | Quin-G | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219559 | Quin-Release | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2195590 | Product containing serotonin uptake inhibitor (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195590 | Product containing serotonin uptake inhibitor (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195591 | Potassium channel activator-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195591 | Potassium channel activator-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219561 | Quinamm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219564 | Quindal HD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219565 | Quineprox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219567 | R & C | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2195691 | Antimonic acid-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195691 | Antimonic acid-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195692 | Equine antithymocyte immunoglobulin-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195692 | Equine antithymocyte immunoglobulin-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219570 | R A Acne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219576 | RMS | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219577 | RT Capsin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219579 | RabAvert | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2195790 | Metal and/or metallic compound-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195790 | Metal and/or metallic compound-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195791 | Boric acid- and salicylic acid-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195791 | Boric acid- and salicylic acid-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195793 | Cytochrome P450 inhibitor-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195793 | Cytochrome P450 inhibitor-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195795 | Naphazoline- and polyvinyl alcohol- and zinc sulfate-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195795 | Naphazoline- and polyvinyl alcohol- and zinc sulfate-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195796 | Interferon gamma inhibitor-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195796 | Interferon gamma inhibitor-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195797 | Nitrogen radioisotope-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195797 | Nitrogen radioisotope-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195798 | Norcholestenol iodomethyl (131-I)-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195798 | Norcholestenol iodomethyl (131-I)-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195799 | Ammonium lactate- and salicylic acid-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195799 | Ammonium lactate- and salicylic acid-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195801 | Product containing transthyretin synthesis inhibitor (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195801 | Product containing transthyretin synthesis inhibitor (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195802 | Product containing xenon radioisotope (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195802 | Product containing xenon radioisotope (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 219581 | Ramses Personal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219584 | Rauzide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219585 | Re-Azo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219586 | Rea-Lo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2195890 | Potassium chloride 100 mg/mL oral solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195890 | Potassium chloride 100 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195891 | Product containing precisely Sterculia gum 620 milligram/1 milliliter conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195891 | Product containing precisely Sterculia gum 620 milligram/1 milliliter conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195892 | Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195892 | Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2195893 | Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2195893 | Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219591 | Recort Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219592 | Rectacaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219595 | Rederm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219598 | Redutemp | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219602 | Regonol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219603 | Regranex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219605 | Reguloid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219606 | Relaxazone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2196092 | upadacitinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2196092 | upadacitinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2196092 | upadacitinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2196092 | upadacitinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2196092 | upadacitinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 219610 | Remicade | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219611 | Remular | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219612 | Remular-S | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219615 | Renese-R | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219620 | Renovue-65 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219624 | Repan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219625 | Repan CF | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2196290 | immune globulin subcutaneous (human) - klhw | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2196291 | immune globulin subcutaneous (human) - klhw 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2196292 | immune globulin subcutaneous (human) - klhw 20 % (1 GM per 5 ML) Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2196292 | immune globulin subcutaneous (human) - klhw 20 % (1 GM per 5 ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196293 | Xembify | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2196294 | immune globulin subcutaneous (human) - klhw 200 MG/ML [Xembify] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2196295 | immunoglobulin G Injection [Xembify] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2196296 | Xembify Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2196297 | Xembify 20 % (1 GM in 5 ML) Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2196297 | Xembify 20 % (1 GM in 5 ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196297 | Xembify 20 % (1 GM in 5 ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196297 | Xembify 20 % (1 GM in 5 ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196298 | immune globulin subcutaneous (human) - klhw 200 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2196299 | immune globulin subcutaneous (human) - klhw 200 MG/ML Injection [Xembify] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2196299 | immune globulin subcutaneous (human) - klhw 200 MG/ML Injection [Xembify] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 219632 | Rescudose | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219636 | Respa-GF | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2196390 | immune globulin subcutaneous (human) - klhw 20 % (2 GM per 10 ML) Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2196390 | immune globulin subcutaneous (human) - klhw 20 % (2 GM per 10 ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196391 | Xembify 20 % (2 GM in 10 ML) Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2196391 | Xembify 20 % (2 GM in 10 ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196391 | Xembify 20 % (2 GM in 10 ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196391 | Xembify 20 % (2 GM in 10 ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 219641 | Restoril | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219642 | Retavase | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219644 | Rev-Eyes | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219645 | Reversol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219646 | Revex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219648 | Rexolate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219649 | Rezamid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2196490 | immune globulin subcutaneous (human) - klhw 20 % (4 GM per 20 ML) Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2196490 | immune globulin subcutaneous (human) - klhw 20 % (4 GM per 20 ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196491 | Xembify 20 % (4 GM in 20 ML) Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2196491 | Xembify 20 % (4 GM in 20 ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196491 | Xembify 20 % (4 GM in 20 ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196491 | Xembify 20 % (4 GM in 20 ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196492 | immune globulin subcutaneous (human) - klhw 20 % (10 GM per 50 ML) Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2196492 | immune globulin subcutaneous (human) - klhw 20 % (10 GM per 50 ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196493 | Xembify 20 % (10 GM in 50 ML) Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2196493 | Xembify 20 % (10 GM in 50 ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196493 | Xembify 20 % (10 GM in 50 ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196493 | Xembify 20 % (10 GM in 50 ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 21965 | Chlorguanide triazide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21965 | Chlorguanide triazide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21965 | Chlorguanide triazide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219650 | Rezine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219651 | Rheaban Maximum Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219655 | Rhindecon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2196590 | mometasone furoate/formoterol fumarate 50/5 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2196590 | mometasone furoate/formoterol fumarate 50/5 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196591 | formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.05 MG/ACTUAT [Dulera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2196592 | Dulera 50/5 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2196592 | Dulera 50/5 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196592 | Dulera 50/5 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196592 | Dulera 50/5 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196592 | Dulera 50/5 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196593 | formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.05 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 219665 | Ri-Mag | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219666 | Ri-Mox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219667 | Ri-Mox Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2196690 | formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.05 MG/ACTUAT Metered Dose Inhaler [Dulera] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 219672 | Ridactate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219673 | Ridafed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219674 | Ridenol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219675 | Ridifed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219676 | Ridiprin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219679 | Rifamate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2196790 | mometasone furoate 50 MCG/INHAL Metered Dose Inhaler, 120 ACTUAT | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2196790 | mometasone furoate 50 MCG/INHAL Metered Dose Inhaler, 120 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196791 | mometasone furoate 0.05 MG/ACTUAT [Asmanex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2196792 | Asmanex HFA 50 MCG/INHAL Metered Dose Inhaler, 120 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196792 | Asmanex HFA 50 MCG/INHAL Metered Dose Inhaler, 120 ACTUAT | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2196792 | Asmanex HFA 50 MCG/INHAL Metered Dose Inhaler, 120 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196792 | Asmanex HFA 50 MCG/INHAL Metered Dose Inhaler, 120 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196792 | Asmanex HFA 50 MCG/INHAL Metered Dose Inhaler, 120 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196793 | mometasone furoate 0.05 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2196794 | mometasone furoate 0.05 MG/ACTUAT Metered Dose Inhaler [Asmanex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2196794 | mometasone furoate 0.05 MG/ACTUAT Metered Dose Inhaler [Asmanex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 219681 | Rindal-HD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219682 | Riopan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219683 | Riopan Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219688 | Robafen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219689 | Robafen AC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2196890 | upadacitinib 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2196891 | upadacitinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2196891 | upadacitinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2196891 | upadacitinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2196892 | upadacitinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2196893 | upadacitinib Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2196894 | upadacitinib 15 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2196894 | upadacitinib 15 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196895 | Rinvoq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2196896 | upadacitinib 15 MG [Rinvoq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2196897 | upadacitinib Extended Release Oral Tablet [Rinvoq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2196898 | Rinvoq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2196899 | Rinvoq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2196900 | RINVOQ 15 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196900 | RINVOQ 15 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2196900 | RINVOQ 15 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2196900 | RINVOQ 15 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2196901 | upadacitinib 15 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2196902 | upadacitinib 15 MG Extended Release Oral Tablet [Rinvoq] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2196902 | upadacitinib 15 MG Extended Release Oral Tablet [Rinvoq] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 219696 | Robichem | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219697 | Robichem AC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2196992 | Bactoshield 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2196992 | Bactoshield 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2196992 | Bactoshield 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 219701 | Robitet 500 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2197110 | sodium chloride 7.2 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2197110 | sodium chloride 7.2 % in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2197110 | sodium chloride 7.2 % in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2197110 | sodium chloride 7.2 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2197148 | Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2197148 | Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219721 | Rolaids | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219723 | Rolatuss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2197238 | benzocaine 10 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2197238 | benzocaine 10 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2197238 | benzocaine 10 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2197239 | Ampicillin (as ampicillin sodium) 250 mg and floxacillin (as floxacillin sodium) 250 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2197239 | Ampicillin (as ampicillin sodium) 250 mg and floxacillin (as floxacillin sodium) 250 mg powder for solution for injection vial | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2197239 | Ampicillin (as ampicillin sodium) 250 mg and floxacillin (as floxacillin sodium) 250 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219724 | Rolatuss with Hydrocodone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219724 | Rolatuss with Hydrocodone | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 219727 | Romilar AC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219728 | Romycin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219729 | Rondameth | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2197290 | dengue virus live antigen, CYD serotype 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2197291 | dengue virus live antigen, CYD serotype 2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2197292 | dengue virus live antigen, CYD serotype 3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2197293 | dengue virus live antigen, CYD serotype 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2197298 | dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2197300 | dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 219734 | Ronoxidil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219739 | Roxicet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2197390 | dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 219740 | Roxicodone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219741 | Roxilox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219742 | Roxiprin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2197490 | Fedratinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2197490 | Fedratinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197490 | Fedratinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197490 | Fedratinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197490 | Fedratinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197491 | fedratinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2197492 | Fedratinib-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2197492 | Fedratinib-containing product in oral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197492 | Fedratinib-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197493 | fedratinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2197494 | fedratinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2197495 | fedratinib 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197495 | fedratinib 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197495 | fedratinib 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197495 | fedratinib 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2197495 | fedratinib 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197496 | Inrebic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2197497 | fedratinib 100 MG [Inrebic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2197498 | fedratinib Oral Capsule [Inrebic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197499 | Inrebic Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2197500 | Inrebic Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2197501 | INREBIC 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197501 | INREBIC 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197501 | INREBIC 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197501 | INREBIC 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 219752 | Rx Triamcinolone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2197593 | Pyrantel tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2197593 | Pyrantel tartrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2197593 | Pyrantel tartrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2197594 | fedratinib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2197594 | fedratinib hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197594 | fedratinib hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 21976 | Cyclohexanone monooxygenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21976 | Cyclohexanone monooxygenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219764 | S-T Febrol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219765 | S-T Forte | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219766 | S-T Forte 2 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219768 | SLT | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219769 | SRC Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2197691 | Dengvaxia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2197693 | dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197694 | Dengvaxia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2197697 | dengue virus live antigen, CYD serotype 1 100000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2197698 | dengue virus live antigen, CYD serotype 2 100000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2197699 | dengue virus live antigen, CYD serotype 3 100000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 219770 | SSD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2197700 | dengue virus live antigen, CYD serotype 4 100000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2197701 | dengue tetravalent vaccine live 0.5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197701 | dengue tetravalent vaccine live 0.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197701 | dengue tetravalent vaccine live 0.5 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2197702 | dengue virus live antigen, CYD serotype 1 100000 UNT / dengue virus live antigen, CYD serotype 2 100000 UNT / dengue virus live antigen, CYD serotype 3 100000 UNT / dengue virus live antigen, CYD serotype 4 100000 UNT [Dengvaxia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2197703 | dengvaxia tetravalent vaccine live 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197703 | dengvaxia tetravalent vaccine live 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197703 | dengvaxia tetravalent vaccine live 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197729 | Ethinylestradiol- and ferrous fumarate- and norethisterone-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2197729 | Ethinylestradiol- and ferrous fumarate- and norethisterone-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2197729 | Ethinylestradiol- and ferrous fumarate- and norethisterone-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219778 | Sal-Tropine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219779 | Saleto | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219780 | Saleto-200 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219781 | Saleto-400 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219782 | Saleto-600 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219783 | Saleto-800 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2197842 | baloxavir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2197842 | baloxavir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197842 | baloxavir | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197842 | baloxavir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197842 | baloxavir | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197844 | lidocaine 4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197844 | lidocaine 4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197844 | lidocaine 4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2197846 | salicylic acid 0.01 % Topical Swab | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2197846 | salicylic acid 0.01 % Topical Swab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2197846 | salicylic acid 0.01 % Topical Swab | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2197847 | Cefpirome (as cefpirome sulfate) 1 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2197847 | Cefpirome (as cefpirome sulfate) 1 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2197847 | Cefpirome (as cefpirome sulfate) 1 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2197847 | Cefpirome (as cefpirome sulfate) 1 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2197861 | Cefuroxime (as cefuroxime axetil) 125 mg granules for oral suspension sachet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2197861 | Cefuroxime (as cefuroxime axetil) 125 mg granules for oral suspension sachet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2197862 | entrectinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2197862 | entrectinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197862 | entrectinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197862 | entrectinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197862 | entrectinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197863 | entrectinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2197864 | entrectinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2197864 | entrectinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197864 | entrectinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197865 | entrectinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2197866 | entrectinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2197867 | entrectinib 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197867 | entrectinib 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2197868 | Rozlytrek | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2197869 | entrectinib 100 MG [Rozlytrek] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2197870 | entrectinib Oral Capsule [Rozlytrek] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197871 | Rozlytrek Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2197872 | Rozlytrek Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2197873 | ROZLYTREK 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197873 | ROZLYTREK 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197873 | ROZLYTREK 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197874 | entrectinib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2197875 | entrectinib 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197875 | entrectinib 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2197876 | entrectinib 200 MG [Rozlytrek] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2197877 | ROZLYTREK 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197877 | ROZLYTREK 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197877 | ROZLYTREK 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197878 | Pitolisant | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2197878 | Pitolisant | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197878 | Pitolisant | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197878 | Pitolisant | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197878 | Pitolisant | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197879 | pitolisant hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2197879 | pitolisant hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197879 | pitolisant hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197880 | pitolisant 4.45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2197881 | pitolisant Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2197881 | pitolisant Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197881 | pitolisant Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197882 | pitolisant Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2197883 | pitolisant Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2197884 | pitolisant 4.45 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197884 | pitolisant 4.45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197884 | pitolisant 4.45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197884 | pitolisant 4.45 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2197884 | pitolisant 4.45 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197885 | Wakix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2197886 | pitolisant 4.45 MG [Wakix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2197887 | pitolisant Oral Tablet [Wakix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197888 | Wakix Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2197889 | Wakix Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2197890 | Wakix 4.45 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197890 | Wakix 4.45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197890 | Wakix 4.45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197890 | Wakix 4.45 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197891 | pitolisant 17.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2197892 | pitolisant 17.8 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2197892 | pitolisant 17.8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197892 | pitolisant 17.8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197892 | pitolisant 17.8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2197892 | pitolisant 17.8 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2197893 | pitolisant 17.8 MG [Wakix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2197894 | Wakix 17.8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2197894 | Wakix 17.8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2197894 | Wakix 17.8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2197894 | Wakix 17.8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 21979 | Cyclohexylamine oxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21979 | Cyclohexylamine oxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219790 | Salinex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219796 | Salsitab | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219797 | Salutensin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219798 | Salutensin-Demi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219799 | Sandostatin LAR | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219799 | Sandostatin LAR | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2197995 | Cleome gynandra leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 219800 | Sangcya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219803 | Santyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219806 | Sarnol-HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219807 | Sastid Soap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219808 | Satogesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219813 | Scalp-Aid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219814 | Scalp-Cort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219815 | Sclavo Test-PPD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219816 | Sclromate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219817 | Scopace | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219819 | Scot Tussin Original | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219820 | Scot-Tussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219823 | Scot-Tussin DM Cough Chasers | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219828 | Sea Mist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219829 | Sea Soft | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219831 | Sea-Omega | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219832 | Seba-Gel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219834 | Sebasorb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219835 | Sebex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2198358 | dimethicone methacrylate (3000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2198359 | pretomanid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2198359 | pretomanid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2198359 | pretomanid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2198359 | pretomanid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2198359 | pretomanid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 219836 | Sebizon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2198366 | pretomanid 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198367 | pretomanid Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2198367 | pretomanid Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2198367 | pretomanid Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2198368 | pretomanid Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2198369 | pretomanid Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 219837 | Sebucare | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2198370 | pretomanid 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198370 | pretomanid 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 219838 | Sebulex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219840 | Sebulon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219841 | Sebutone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219842 | Secretin-Ferring | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2198427 | Nocita | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219843 | Sedapap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219844 | Sel-Pen Blue | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219848 | Selestoject | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219850 | Selsun Blue | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219857 | Semprex-D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219859 | Senexon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219860 | senna concentrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 219862 | Senna-Relief Childs | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219866 | SENOKOT-S | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219867 | Senolax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219868 | Senormin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219869 | Senox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219871 | Sensorcaine with Epinephrine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219871 | Sensorcaine with Epinephrine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 219874 | Septa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219877 | Septisol Foam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219878 | Ser-Ap-Es | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219879 | Serathide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2198792 | sodium bicarbonate 4.2 % (5 MEQ) in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198792 | sodium bicarbonate 4.2 % (5 MEQ) in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2198792 | sodium bicarbonate 4.2 % (5 MEQ) in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198792 | sodium bicarbonate 4.2 % (5 MEQ) in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198793 | turpentine 90 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2198794 | camphor / turpentine Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2198795 | camphor 3 % / turpentine oil 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2198795 | camphor 3 % / turpentine oil 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2198795 | camphor 3 % / turpentine oil 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2198796 | phenol 1.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2198796 | phenol 1.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2198796 | phenol 1.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21988 | Bacillus macerans amylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21988 | Bacillus macerans amylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21988 | Bacillus macerans amylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21988 | Bacillus macerans amylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219881 | Serpazide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219882 | Serpex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219887 | Seudotabs | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2198891 | menthyl salicylate 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2198892 | menthol / menthyl salicylate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2198893 | menthol / menthyl salicylate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2198894 | menthol / menthyl salicylate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2198895 | menthol 2 % / menthyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2198895 | menthol 2 % / menthyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2198895 | menthol 2 % / menthyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2198896 | influenza A virus A/Switzerland/3330/2017 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2198897 | influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198898 | influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198899 | influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen / influenza B virus B/Colorado/06/2017 antigen / influenza B virus B/Phuket/3073/2013 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2198900 | influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2198901 | FluMist Quadrivalent 2019-2020 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2198902 | influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [FluMist Quadrivalent 2019-2020] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2198903 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist Quadrivalent 2019-2020] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2198904 | FluMist Quadrivalent 2019-2020 Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2198905 | FluMist Quadrivalent 2019-2020 Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2198906 | FluMist Quadrivalent, 2019-2020 Formula Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198906 | FluMist Quadrivalent, 2019-2020 Formula Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198906 | FluMist Quadrivalent, 2019-2020 Formula Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 219892 | Siderol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2198932 | benzoyl peroxide 52 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198933 | benzoyl peroxide 5.2 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198933 | benzoyl peroxide 5.2 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198933 | benzoyl peroxide 5.2 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2198934 | benzoyl peroxide 58 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198935 | benzoyl peroxide 5.8 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198935 | benzoyl peroxide 5.8 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198935 | benzoyl peroxide 5.8 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2198936 | benzoyl peroxide 68 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198937 | benzoyl peroxide 6.8 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198937 | benzoyl peroxide 6.8 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198937 | benzoyl peroxide 6.8 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2198939 | benzoyl peroxide 69 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198940 | benzoyl peroxide 6.9 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198940 | benzoyl peroxide 6.9 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198940 | benzoyl peroxide 6.9 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2198941 | benzoyl peroxide 97 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198942 | benzoyl peroxide 9.7 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198942 | benzoyl peroxide 9.7 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198942 | benzoyl peroxide 9.7 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2198943 | lefamulin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2198944 | Lefamulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2198944 | Lefamulin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2198944 | Lefamulin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2198944 | Lefamulin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2198944 | Lefamulin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2198945 | lefamulin 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198946 | Lefamulin-containing product in parenteral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2198946 | Lefamulin-containing product in parenteral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2198946 | Lefamulin-containing product in parenteral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2198947 | lefamulin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2198948 | lefamulin 150 MG in 15 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2198948 | lefamulin 150 MG in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198948 | lefamulin 150 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198949 | Xenleta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2198950 | lefamulin 10 MG/ML [Xenleta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2198951 | lefamulin Injection [Xenleta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2198952 | Xenleta Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2198953 | Xenleta 150 MG in 15 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2198953 | Xenleta 150 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198953 | Xenleta 150 MG in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198953 | Xenleta 150 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198954 | lefamulin 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2198955 | lefamulin 10 MG/ML Injection [Xenleta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2198955 | lefamulin 10 MG/ML Injection [Xenleta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2198957 | lefamulin 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2198958 | Lefamulin-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2198958 | Lefamulin-containing product in oral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2198958 | Lefamulin-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2198959 | lefamulin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 219896 | Siladryl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2198960 | lefamulin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2198961 | lefamulin 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198961 | lefamulin 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2198962 | lefamulin 600 MG [Xenleta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2198963 | lefamulin Oral Tablet [Xenleta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2198964 | Xenleta Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2198965 | Xenleta Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2198966 | Xenleta 600 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2198966 | Xenleta 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2198966 | Xenleta 600 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2198968 | menthol 1.25 % / methyl salicylate 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2198968 | menthol 1.25 % / methyl salicylate 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2198968 | menthol 1.25 % / methyl salicylate 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2198969 | camphor 3.5 % / menthol 2.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2198969 | camphor 3.5 % / menthol 2.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2198969 | camphor 3.5 % / menthol 2.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2198970 | camphor 5 % / menthol 2.8 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2198970 | camphor 5 % / menthol 2.8 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2198970 | camphor 5 % / menthol 2.8 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2198971 | magnesium laureth-8 sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2198972 | Crataegus laevigata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2198973 | eletriptan hydrobromide monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2198973 | eletriptan hydrobromide monohydrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2198973 | eletriptan hydrobromide monohydrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2198974 | ropivacaine hydrochloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2198975 | methylene blue anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2198976 | sodium acetylated hyaluronate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2198978 | salsolinol hydrochloride, (+/-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2198979 | catfish allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2198980 | catfish allergenic extract 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2198981 | catfish allergenic extract Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2198982 | catfish allergenic extract Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2198983 | catfish allergenic extract 50 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2198983 | catfish allergenic extract 50 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2198983 | catfish allergenic extract 50 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2198984 | Scomber scombrus allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2198984 | Scomber scombrus allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2198985 | Atlantic mackerel allergenic extract 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2198986 | Atlantic mackerel allergenic extract Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2198987 | Atlantic mackerel allergenic extract Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2198988 | Atlantic mackerel allergenic extract 50 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2198988 | Atlantic mackerel allergenic extract 50 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2198988 | Atlantic mackerel allergenic extract 50 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 21990 | cyclomethycaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 21990 | cyclomethycaine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21990 | cyclomethycaine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2199015 | istradefylline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2199015 | istradefylline | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2199015 | istradefylline | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2199015 | istradefylline | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2199015 | istradefylline | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2199016 | istradefylline 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2199017 | istradefylline Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2199017 | istradefylline Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2199017 | istradefylline Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2199018 | istradefylline Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2199019 | istradefylline Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2199020 | istradefylline 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199020 | istradefylline 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199021 | Nourianz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2199022 | istradefylline 20 MG [Nourianz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2199023 | istradefylline Oral Tablet [Nourianz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199024 | Nourianz Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2199025 | Nourianz Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2199026 | NOURIANZ 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199026 | NOURIANZ 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199026 | NOURIANZ 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199027 | istradefylline 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2199028 | istradefylline 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199028 | istradefylline 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199029 | istradefylline 40 MG [Nourianz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2199030 | NOURIANZ 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199030 | NOURIANZ 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199030 | NOURIANZ 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199031 | butyl acrylate - methylacrylate acid copolymer (2 % methacrylic acid) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2199033 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199034 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML [C-Tanna 12] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199035 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [C-Tanna 12] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199035 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [C-Tanna 12] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199036 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML [Tannic-12 S] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199037 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tannic-12 S] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199037 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tannic-12 S] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199037 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tannic-12 S] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199038 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML [Ricotuss] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199039 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Ricotuss] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199039 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Ricotuss] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 219904 | Siltane | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2199042 | Lutropin, alpha subunit | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2199042 | Lutropin, alpha subunit | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2199043 | Thyrotropin alpha subunit | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199044 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML [Tannate 12 S] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199045 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tannate 12 S] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199045 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tannate 12 S] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199046 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML [Tannihist 12 RF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199047 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tannihist 12 RF] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199047 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tannihist 12 RF] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199049 | chlorhexidine gluconate 20 MG/ML / isopropyl alcohol 0.7 ML/ML [ChloraPrep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2199050 | chlorhexidine / isopropyl alcohol Topical Solution [ChloraPrep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199051 | ChloraPrep Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 219906 | Siltussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219908 | Simaal Gel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219911 | Simron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219912 | Simulect | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2199126 | Dyclopro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2199127 | dyclonine hydrochloride 10 MG/ML [Dyclopro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199128 | dyclonine Mucous Membrane Topical Solution [Dyclopro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199129 | Dyclopro Mucosal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2199130 | DycloPro 1 % Mucous Membrane Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199130 | DycloPro 1 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2199130 | DycloPro 1 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199130 | DycloPro 1 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199131 | dyclonine hydrochloride 5 MG/ML [Dyclopro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2199132 | DycloPro 0.5 % Mucous Membrane Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199132 | DycloPro 0.5 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199132 | DycloPro 0.5 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199132 | DycloPro 0.5 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199135 | lidocaine 35 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2199136 | lidocaine 3.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199136 | lidocaine 3.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199136 | lidocaine 3.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199137 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML [Trionate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199138 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Trionate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199138 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Trionate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199139 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML [Tussi-12] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199140 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tussi-12] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199140 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tussi-12] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199140 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tussi-12] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199141 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML [Tussizone-12 RF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199142 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tussizone-12 RF] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199142 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tussizone-12 RF] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199143 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML [Tustan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199144 | carbetapentane tannate 6 MG/ML / chlorpheniramine tannate 0.8 MG/ML Oral Suspension [Tustan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199145 | chlorpheniramine maleate 12 MG / phenylpropanolamine HCl 75 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199145 | chlorpheniramine maleate 12 MG / phenylpropanolamine HCl 75 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199145 | chlorpheniramine maleate 12 MG / phenylpropanolamine HCl 75 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199146 | chlorpheniramine maleate 12 MG / phenylpropanolamine hydrochloride 75 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199151 | chlorpheniramine maleate 8 MG / phenylpropanolamine HCl 75 MG 12 HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199151 | chlorpheniramine maleate 8 MG / phenylpropanolamine HCl 75 MG 12 HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199154 | chlorpheniramine maleate 8 MG / phenylpropanolamine HCl 75 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2199154 | chlorpheniramine maleate 8 MG / phenylpropanolamine HCl 75 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 219917 | Sinarest Nasal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2199218 | Mono-oligosaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199219 | D-glycerate dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 219922 | Sinex Long-Acting | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2199220 | Vaginal System | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 2199290 | cellaburate (MW 65000, 17 % butyryl, 30 % acetyl) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2199291 | evodiamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199292 | Liquidambar orientalis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199293 | Arisaema erubescens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199294 | Tetrapanax papyrifer stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199295 | menthol 0.0462 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2199296 | menthol 4.62 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199296 | menthol 4.62 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2199296 | menthol 4.62 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199297 | glucagon 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2199298 | glucagon Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2199299 | glucagon 0.5 MG in 0.1 mL Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199299 | glucagon 0.5 MG in 0.1 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199299 | glucagon 0.5 MG in 0.1 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 21993 | cyclonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199300 | Gvoke | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2199301 | glucagon 5 MG/ML [Gvoke] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2199302 | glucagon Auto-Injector [Gvoke] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199303 | Gvoke Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2199304 | Gvoke HypoPen 0.5 MG in 0.1 mL Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199304 | Gvoke HypoPen 0.5 MG in 0.1 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199304 | Gvoke HypoPen 0.5 MG in 0.1 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199304 | Gvoke HypoPen 0.5 MG in 0.1 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199305 | glucagon 5 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199306 | glucagon 5 MG/ML Auto-Injector [Gvoke] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199306 | glucagon 5 MG/ML Auto-Injector [Gvoke] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199307 | glucagon 1 MG in 0.2 mL Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199307 | glucagon 1 MG in 0.2 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199307 | glucagon 1 MG in 0.2 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199308 | Gvoke HypoPen 1 MG in 0.2 mL Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199308 | Gvoke HypoPen 1 MG in 0.2 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199308 | Gvoke HypoPen 1 MG in 0.2 mL Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199308 | Gvoke HypoPen 1 MG in 0.2 mL Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199309 | glucagon Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 219931 | Sinumist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2199310 | glucagon 0.5 MG in 0.1 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199310 | glucagon 0.5 MG in 0.1 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199310 | glucagon 0.5 MG in 0.1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199311 | glucagon Prefilled Syringe [Gvoke] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199312 | Gvoke PFS 0.5 MG in 0.1 mL Pre-Filled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199312 | Gvoke PFS 0.5 MG in 0.1 mL Pre-Filled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199312 | Gvoke PFS 0.5 MG in 0.1 mL Pre-Filled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199312 | Gvoke PFS 0.5 MG in 0.1 mL Pre-Filled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199313 | glucagon 5 MG per 1 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199313 | glucagon 5 MG per 1 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199314 | glucagon 5 MG/ML Prefilled Syringe [Gvoke] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199314 | glucagon 5 MG/ML Prefilled Syringe [Gvoke] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199315 | glucagon 1 MG in 0.2 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199315 | glucagon 1 MG in 0.2 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199315 | glucagon 1 MG in 0.2 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199316 | Gvoke PFS 1 MG in 0.2 mL Pre-Filled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199316 | Gvoke PFS 1 MG in 0.2 mL Pre-Filled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199316 | Gvoke PFS 1 MG in 0.2 mL Pre-Filled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199316 | Gvoke PFS 1 MG in 0.2 mL Pre-Filled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199317 | lidocaine 3.5 % / menthol 7 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199317 | lidocaine 3.5 % / menthol 7 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199317 | lidocaine 3.5 % / menthol 7 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199323 | methylene blue 10 MG in 2 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199323 | methylene blue 10 MG in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199323 | methylene blue 10 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199324 | ProvayBlue 10 MG in 2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199324 | ProvayBlue 10 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199324 | ProvayBlue 10 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199324 | ProvayBlue 10 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199325 | zingerone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2199390 | camphor 4 % / menthol 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199390 | camphor 4 % / menthol 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199390 | camphor 4 % / menthol 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199391 | edotreotide gallium ga-68 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2199392 | edotreotride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199490 | edible rock crab preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199491 | Pacific oyster preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 219956 | Sleepinal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219957 | Slo-Niacin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2199576 | A-oligosaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199577 | indocyanine green acid form | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 219960 | Slo-Phyllin GG | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219961 | Sloprin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219962 | Slow Fe with Folic Acid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219963 | Slow-Mag | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2199635 | dimethoxydiphenylsilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 219964 | Sochlor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2199647 | dexchlorpheniramine maleate 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2199648 | dexchlorpheniramine 3 MG / phenylephrine 20 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199648 | dexchlorpheniramine 3 MG / phenylephrine 20 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199651 | dexchlorpheniramine maleate 3 MG / phenylephrine hydrochloride 20 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199653 | chlorokojic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199654 | PEG-7 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199655 | chlorpheniramine maleate 12 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199656 | chlorpheniramine maleate 12 MG [Qdall AR] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199657 | chlorpheniramine maleate 12 MG Extended Release Oral Capsule [Qdall AR] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199657 | chlorpheniramine maleate 12 MG Extended Release Oral Capsule [Qdall AR] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199658 | chlorpheniramine maleate 12 MG [Chlor-Phen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199659 | Chlor-Phen 12 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2199659 | Chlor-Phen 12 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199659 | Chlor-Phen 12 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199662 | chlorpheniramine maleate 12 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199662 | chlorpheniramine maleate 12 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199662 | chlorpheniramine maleate 12 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2199665 | lidocaine 3.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199665 | lidocaine 3.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199665 | lidocaine 3.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199666 | chlorpheniramine maleate 16 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2199667 | chlorpheniramine maleate 16 MG 24 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199667 | chlorpheniramine maleate 16 MG 24 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199668 | chlorpheniramine maleate 16 MG [Efidac-24 Chlorpheniramine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199669 | 24 HR chlorpheniramine maleate 16 MG Extended Release Oral Tablet [Efidac-24 Chlorpheniramine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199669 | 24 HR chlorpheniramine maleate 16 MG Extended Release Oral Tablet [Efidac-24 Chlorpheniramine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199669 | 24 HR chlorpheniramine maleate 16 MG Extended Release Oral Tablet [Efidac-24 Chlorpheniramine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199670 | chlorpheniramine maleate 16 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199671 | chlorpheniramine maleate 16 MG Extended Release Oral Tablet [Efidac-24 Chlorpheniramine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2199672 | lidocaine 3.5 % / menthol 7 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199672 | lidocaine 3.5 % / menthol 7 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199672 | lidocaine 3.5 % / menthol 7 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199673 | tenapanor hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2199674 | tenapanor | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2199674 | tenapanor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2199674 | tenapanor | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2199674 | tenapanor | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2199674 | tenapanor | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2199675 | tenapanor 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2199676 | tenapanor Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2199676 | tenapanor Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2199676 | tenapanor Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2199677 | tenapanor Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2199678 | tenapanor Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2199679 | tenapanor 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199679 | tenapanor 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199679 | tenapanor 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2199680 | Ibsrela | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2199681 | tenapanor 50 MG [Ibsrela] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2199682 | tenapanor Oral Tablet [Ibsrela] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199683 | Ibsrela Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2199684 | Ibsrela Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2199685 | Ibsrela 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2199685 | Ibsrela 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2199685 | Ibsrela 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2199688 | chlorpheniramine maleate 12 MG / phenylpropanolamine HCl 75 MG 12 HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199688 | chlorpheniramine maleate 12 MG / phenylpropanolamine HCl 75 MG 12 HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199689 | chlorpheniramine maleate 12 MG / phenylpropanolamine hydrochloride 75 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 219969 | Sodium Sulamyd | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219972 | Solaquin Forte | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219974 | Solarcaine Plus Aloe | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 219975 | Solfoton | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219976 | Solu-Phyllin GG | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219979 | Soma Compound | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 21998 | Cyclopamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21998 | Cyclopamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 219980 | Soma Compound with Codeine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219982 | Somnicaps | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2199845 | pseudoephedrine hydrochloride 0.375 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2199847 | chlorpheniramine maleate 0.25 MG/ML / codeine phosphate 1 MG/ML / pseudoephedrine hydrochloride 0.375 MG/ML [Zodryl DAC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 219985 | Sorbutuss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2199850 | chlorpheniramine maleate 0.266 MG/ML / codeine phosphate 1 MG/ML / pseudoephedrine hydrochloride 4 MG/ML [Zodryl DAC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199852 | chlorpheniramine maleate 0.286 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2199854 | chlorpheniramine maleate 0.286 MG/ML / codeine phosphate 1 MG/ML / pseudoephedrine hydrochloride 4.29 MG/ML [Zodryl DAC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199857 | chlorpheniramine maleate 0.333 MG/ML / codeine phosphate 1 MG/ML / pseudoephedrine hydrochloride 5 MG/ML [Zodryl DAC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2199864 | PEG-8 isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2199868 | benzoyl peroxide Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2199869 | benzoyl peroxide 2.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2199869 | benzoyl peroxide 2.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2199869 | benzoyl peroxide 2.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2199887 | chlorpheniramine maleate 0.4 MG/ML / codeine phosphate 1 MG/ML / pseudoephedrine hydrochloride 6 MG/ML [Zodryl DAC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 219989 | Spacol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2199890 | chlorpheniramine maleate 0.4 MG/ML / codeine phosphate 1.8 MG/ML [Z Tuss AC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 219991 | Spantuss HD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219992 | Spasmolin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219993 | Spasquid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219994 | Spastolate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219995 | Spastrin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219996 | Spec-T | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 219997 | Spec-T Sore Throat/Cough Suppressant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |